ArticleEuropean urology open science2025

Re: Kaushik P. Kolanukuduru, Reuben Ben-David, Sarah Lidagoster, et al. Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Focus 2025;11:142-9.

Zhiyu Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.